Can-fite Biopharma(CANF)

3.19 -0.11 -3.3333%

今开:3.24昨收:3.3
最高:3.33 最低:2.98
涨停价:0.0跌停价:0.0
总市值:1.5919465E7

Can-fite Biopharma的热门讨论

财报披露

Can-fite Biopharma(CANF)07-29 19:05

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001013762-24-001791  Act: 34  Size: 22 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)07-11 19:15

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-060625  Act: 34  Size: 24 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)07-01 19:15

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-057535  Act: 34  Size: 42 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)06-28 19:05

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-056848  Act: 34  Size: 25 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)06-24 19:15

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-054980  Act: 34  Size: 22 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)05-06 19:15

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-039894  Act: 34  Size: 24 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)07-04 01:25

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058931  Act: 34  Size: 10 KB 网页链接查看全文

招股说明书

Can-fite Biopharma(CANF)06-29 04:25

$Can-fite Biopharma(CANF)$ 424B7 Prospectus [Rule 424(b)(7)] Accession Number: 0001213900-24-057194  Act: 33  Size: 42 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)05-29 19:35

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-047244  Act: 34  Size: 20 KB 网页链接查看全文

财报披露

Can-fite Biopharma(CANF)05-09 19:05

$Can-fite Biopharma(CANF)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-041020  Act: 34  Size: 24 KB 网页链接查看全文

1 2

Can-fite Biopharma的最新讨论

君2O2022-03-24 23:51

$灿菲特生物制药(CANF)$ 新冠要搞出来了。查看全文

chuminhua2021-12-21 17:53

12月20日, Can-Fite宣布,在Namodenoson治疗肝细胞癌 (HCC)的II期研究的开放标签扩展试验部分,接受治疗的最后一名患者获得了完全缓解 (CR) ,这意味着这名患者的所有癌症病灶全部清除。在接受namodenson治疗后,患者已经存活了5年,在此期间治疗的临床益处包括腹水消失、肝功能正常以及腹腔内散...查看全文

TCLDBY2021-06-29 23:04

$灿菲特生物制药(CANF)$ 该反攻了吧查看全文

牛唐2021-03-31 09:44

$灿菲特生物制药(CANF)$ 的药物Piclidenoson和Namodenoson在现有的六份分销协议中,剩余的潜在里程碑付款高达约1.3亿美元,外加两位数的净销售额分成。$新泰医药(MDGL)$ $泰格医药(SZ300347)$查看全文

枫林居士2021-03-16 22:23

$灿菲特生物制药(CANF)$开盘的时候最牛的是你,最具操作价值的却是$SunLink卫生系统(SSY)$查看全文

枫林居士2021-03-16 22:06

$灿菲特生物制药(CANF)$ 跌到3块才能抄底?查看全文

HySgpr2021-02-13 03:28

$灿菲特生物制药(CANF)$ 继续加,等爆查看全文

1 2 3 4 5 6

Can-fite Biopharma的公告

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-31 AccNo: 0001213900-18-011964 Size: 1 MB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-21 AccNo: 0001213900-18-011493 Size: 22 KB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ F-1 - Registration statement for certain foreign private issuers Filed: 2018-08-08 AccNo: 0001213900-18-010490 Size: 605 KB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ F-1 - Registration statement for certain foreign private issuers Filed: 2018-08-08 AccNo: 0001213900-18-010490 Size: 605 KB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-08 AccNo: 0001213900-18-010486 Size: 4 MB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-08 AccNo: 0001213900-18-010486 Size: 4 MB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-07 AccNo: 0001213900-18-010336 Size: 35 KB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-07 AccNo: 0001213900-18-010336 Size: 35 KB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-06 AccNo: 0001213900-18-010213 Size: 27 KB 网页链接

$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-07-17 AccNo: 0001213900-18-009271 Size: 31 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50